Healthcare Giant Splits Into Two Separate Companies

Fight Censorship, Share This Post!

Johnson and Johnson (J&J) announced Friday that it plans to break up its two companies, separating its consumer health business into its own publicly-traded company.

The health care giant said it would separate the division that sells consumer products like Band-Aids, Listerine and Tylenol from its riskier and faster-growing pharmaceutical and medical device business, according to a company press release. The consumer division, which generates $15 billion in revenue a year, will operate independently in the next 18 to 24 months.


Fight Censorship, Share This Post!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.